Treatment of scleroderma-interstitial lung disease with cyclophosphamide is associated with less progressive fibrosis on serial thoracic high-resolution CT scan than placebo: findings from the scleroderma lung study - Goldin, Jonathan; Elashoff, Robert; Kim, Hyun J; Yan, Xaiohong; Lynch, David; Strollo, Diane; Roth, Michael D; Clements, Philip; Furst, Daniel E; Khanna, Dinesh; Vasunilashorn, Srainnapha; Li, Gang; et al. (Chest, 2009)
Keywords: Cyclophosphamide - therapeutic use; Disease Progression; Double-Blind Method; Female; Humans; Lung Diseases, Interstitial - diagnostic imaging; Lung Diseases, Interstitial - drug therapy; Lung Diseases, Interstitial - physiopathology; Male; Middle Aged; Placebos; Radiography, Thoracic; Scleroderma, Localized - diagnostic imaging; Scleroderma, Localized - drug therapy; Scleroderma, Localized - physiopathology; Skin - drug effects; Skin - physiopathology; Tomography, X-Ray Computed; Treatment Outcome; Vital Capacity